Skip to main content
2025 AABB Annual Meeting Main banner
Final Program


Legend
Presentation Icons
Assessor Sessions
Assessor Sessions
Committee Meetings
Committee Meetings
Foundation Events
Foundation Events
Networking Events
Networking Events
Oral Abstracts
Oral Abstracts

Research and Progress (RAPS) - 1

Research and Progress (RAPS): Whole Blood in Modern Transfusion Practice - A Debate on Evidence and Application

Sunday, October 26, 2025
6:15 PM - 7:30 PM  PT
Room: SDCC 33

    Program Chair(s)

  • Claudia Cohn, MD, PhD (she/her/hers)

    Professor of Laboratory Medicine and Pathology, Director, Blood Bank Laboratory
    University of Minnesota
    Minneapolis, Minnesota

    Disclosure(s): AABB: Consultant/Advisory Board (Ongoing); Fresenius Kabi: Consultant/Advisory Board (Ongoing); ICCBBA: Board of DIrectors (Ongoing)

    • Speaker(s)

  • Courtney Hopkins

    Vice President, Corporate Medical Director
    Vitalant
    Sullivans Island, South Carolina

    Disclosure information not submitted.

  • RM

    Ryan A. Metcalf, MD

    Section Chief, Transfusion Medicine
    University of Utah Health
    Salt Lake City, Utah

    Disclosure information not submitted.

  • PY

    Pampee Young, MD, PhD (she/her/hers)

    Chief Medical Officer
    American Red Cross
    Nashville, District of Columbia

    Disclosure information not submitted.

  • Simon J. Stanworth, FRCP FRCPath DPhil

    Professor of Haematology and Transfusion Medicine; Consultant Haematologist
    University Oxford
    Oxford, England

    Disclosure information not submitted.

The use of whole blood is reemerging as a potential game-changer in transfusion medicine, particularly in trauma and emergency settings. But does the evidence support a shift away from component therapy? In this lively debate, transfusion medicine experts will examine the latest clinical research on whole blood – including randomized trials, registry data, and military and civilian applications – and argue for and against its broader use. The session will explore critical issues such as efficacy, safety, inventory management, regulatory considerations, and patient outcomes. Attendees will leave with a deeper understanding of the current evidence base and the practical implications for adopting whole blood in their own institutions.